In the upgraded clinical trial, when sepsis patients (including ARDS patients) were grouped according to the plasma level of IL-1RA at enrollment, the high IL-1RA level group tended to obtain survival benefits (50). Here, IL1R1 is linked to acute respiratory distress syndrome.